News Channels

12 Mar 2017 BeiGene Announces Initiation of Pivotal Study in China with BTK Inhibitor BGB-3111 in Patients with Relapsed or Refractory CLL/SLL
12 Mar 2017 New Phase 2 studies with filgotinib in small bowel and fistulizing Crohn's disease
10 Mar 2017 Nature Cell Started Commercial Clinical Trials Phase I and II ‘ASTROSTEM,’ Stem Cell Drug for Alzheimer's Disease Treatment in U.S.
09 Mar 2017 ProtoKinetix Announces Start of Phase 1 & Phase 2 Clinical Trials for the use of AAGP™ PKX-001 Treated Islet Cells in the Treatment of Type 1 Diabetes
09 Mar 2017 Servier and Pfizer Announce FDA Clearance of IND Application for UCART19 in Adult Relapsed/Refractory Acute Lymphoblastic Leukemia
09 Mar 2017 Tyrogenex Completes Patient Enrollment in its Phase 2 Trial of Orally Administered Vorolanib for Wet Age-related Macular Degeneration
09 Mar 2017 Nicox resubmits AC-170 (ZERVIATE1) NDA to the U.S. FDA
09 Mar 2017 CyTuVax starts its Phase 2 BE RESPONDER! study
08 Mar 2017 BerGenBio Enters Collaboration With MSD Focused on Clinical Evaluation of BGB324 in Combination With KEYTRUDA® (Pembrolizumab) in Advanced Lung and Breast Cance
08 Mar 2017 Menlo Therapeutics Announces Successful Pruritus Reduction Results from Phase 2 Serlopitant Trial (TCP-102) in 127 Subjects With Prurigo Nodularis
08 Mar 2017 Regenacy Pharmaceuticals Demonstrates Reversal of Chemotherapy-Induced Peripheral Neuropathy with HDAC6 Inhibitor Ricolinostat in Preclinical Model
08 Mar 2017 FDA Accepts sBLA Filing of Soliris(R) (Eculizumab) as a Potential Treatment for Patients with Refractory Generalized Myasthenia Gravis (gMG)
08 Mar 2017 Glenmark Pharmaceuticals Receives FDA Clearance of IND for GSP 304
08 Mar 2017 Celyad obtains FDA approval to initiate the NKR-2 CAR T cells THINK trial in the USA
07 Mar 2017 Cyclenium Pharma Announces a Research Collaboration with The Hospital for Sick Children to Identify Novel Macrocyclic Modulators for Pharmacological Targets in Multiple Therapeutic Areas
07 Mar 2017 Revance Completes Enrollment in Phase 3 Pivotal Trials of RT002 Injectable for the Treatment of Glabellar (Frown) Lines
07 Mar 2017 Daiichi Sankyo Initiates ENTRUST-AF PCI Study Investigating Once-Daily Lixiana® (edoxaban) in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention with Stenting
07 Mar 2017 Akcea and Ionis Announce Positive Results from Pivotal Study of Volanesorsen in Patients with Familial Chylomicronemia Syndrome (FCS)
07 Mar 2017 Novartis' Cosentyx shows almost all psoriasis patients rapidly regain skin clearance following a treatment pause
07 Mar 2017 Sanofi and Regeneron Announce Presentation of Positive Data from Long-Term Pivotal Phase 3 CHRONOS Study of Dupixent® (dupilumab) in Moderate-to-Severe Atopic Dermatitis

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top